Mode
Text Size
Log in / Sign up

TCM influenza research surges after 2020, shifting from clinical practice to mechanistic studiesTraditional Chinese Medicine Research on Influenza Surges After 2020

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret this bibliometric analysis as mapping research trends, not clinical efficacy of TCM for influenza.

This systematic bibliometric and scientometric analysis examined 1,527 publications on Traditional Chinese Medicine (TCM) for influenza, covering literature up to the search date. The study maps publication growth, leading countries, institutions, journals, and scholars, as well as shifts in research focus.

Key findings include a significant growth in publications since 2014, with a rapid upward trend after 2020. China ranked first globally in both publication number and citation frequency. Leading institutions include the Chinese Academy of Sciences, Beijing University of Chinese Medicine, and the China Academy of Chinese Medical Sciences. The Journal of Ethnopharmacology was identified as the most influential journal, and Yang Zifeng ranked first in h-index and publication output.

The analysis reveals a notable shift in research focus from traditional clinical practice toward modern mechanistic investigation and network pharmacology. The authors describe TCM for influenza as a multi-component and multi-target therapeutic model, suggesting integration of mechanistic insights with standardized clinical translation.

As a bibliometric analysis, this study does not provide direct evidence of clinical efficacy for patients. It describes the landscape of existing research rather than testing a specific intervention. The findings highlight research trends and gaps but should not be interpreted as supporting the clinical use of TCM for influenza without further clinical trials.

How this fits prior evidence

This bibliometric analysis confirms the growing research interest in TCM for influenza, aligning with prior coverage showing TCM's potential in other conditions (e.g., 5.86 kg weight loss in obesity, reduced adverse events in ovarian cancer). It extends prior evidence by mapping the shift toward mechanistic studies, contrasting with earlier clinical outcome-focused reports. The analysis does not address vaccine interactions or comparative efficacy, leaving gaps filled by prior coverage on influenza vaccines (e.g., mRNA-1010 superior efficacy in older adults, high-dose vaccine immunogenicity in children).

A systematic review of 1,527 publications on Traditional Chinese Medicine (TCM) for influenza reveals a significant increase in research output since 2014, with a particularly rapid upward trend after 2020. The study, a bibliometric analysis, maps the landscape of TCM research in this area.

China ranks first globally in both the number of publications and citation frequency. Leading institutions include the Chinese Academy of Sciences, Beijing University of Chinese Medicine, and the China Academy of Chinese Medical Sciences. The Journal of Ethnopharmacology is identified as the most influential journal in this field.

Among individual researchers, Yang Zifeng has the highest h-index and publication output. The analysis also shows a shift in research focus from traditional clinical practice toward modern mechanistic investigation and network pharmacology, reflecting a move toward understanding how TCM works at a molecular level.

It is important to note that this is a bibliometric analysis, not a clinical trial. It describes the research landscape but does not provide direct evidence of clinical efficacy for patients. The findings suggest a growing interest in integrating TCM mechanistic insights with standardized clinical translation.

What this means for you:
TCM research for influenza has grown rapidly since 2014, with China leading, and focus shifting to modern mechanistic studies.

Common questions

Does this mean Traditional Chinese Medicine is proven to treat flu?

This study was a bibliometric analysis of 1,527 publications, not a clinical trial. It shows that more research is being published about Traditional Chinese Medicine for influenza, but it does not provide direct evidence of how well the treatment works for patients.

What are researchers focusing on regarding these treatments?

The study found a shift in focus from traditional clinical practice toward modern mechanistic investigation and network pharmacology. This means scientists are trying to understand the specific biological pathways of how these multi-component treatments work.

Is there a lot of research on this topic?

Yes, there has been significant growth in publications since 2014, with a rapid upward trend after 2020. China currently leads the world in both the number of publications and citation frequency regarding these treatments.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
ObjectivesAs an acute respiratory infectious disease, influenza continues to impose a substantial public health burden worldwide. This study aims to systematically review the progress of research on the treatment of influenza with Traditional Chinese Medicine (TCM) from 2005 to 2025, identify current research hotspots, and forecast future development trends, in order to provide a clear and systematic reference framework for subsequent research.MethodsA bibliometric and scientometric analysis was conducted using the Web of Science Core Collection (WOSCC), PubMed, and Scopus databases. Following the PRISMA 2020 guidelines, the retrieved records underwent a comprehensive deduplication process and stringent quality control checks. By comprehensively applying CiteSpace, VOSviewer, and the R-based Bibliometrix package, metrics and visualization were performed across multiple dimensions, including publication volume, geographical contribution, annual trends, national/regional influence, core authors and institutions, and keywords.ResultsA total of 1,527 publications were included in this study. Since 2014, publication output in this field has shown significant growth, with a rapid upward trend emerging after 2020. At the national and institutional level, China ranked first globally in both the number of publications and total citation frequency. Research institutions in China not only serve as the dominant force in this field but also act as hubs for international collaboration. Notable contributions were made by institutions such as the Chinese Academy of Sciences, Beijing University of Chinese Medicine, and the China Academy of Chinese Medical Sciences. Journal analysis revealed that the Journal of Ethnopharmacology is the most influential journal in this domain. In terms of scholarly impact, Yang Zifeng ranked first in both h-index and publication output, establishing them as the most prolific and influential core scholar in the field. Keyword analysis indicated that research focuses on core themes such as “herbal medicine” and “antiviral activity.” The evolutionary trajectory demonstrates a shift from traditional clinical practice toward modern mechanistic investigation. Driven by emerging public health events such as COVID-19, the field has rapidly integrated cutting-edge methodologies like network pharmacology, reflecting distinct characteristics of contemporary responsiveness and interdisciplinary convergence.ConclusionThis analysis confirms that TCM for influenza has matured into a structured and interdisciplinary research field. Substantial evidence supports its multi-component and multi-target therapeutic model as a clinically effective strategy against influenza. Future efforts should prioritize the integration of mechanistic insights with standardized clinical translation to enhance global antiviral preparedness.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.